Physiology-guided vasoactive therapy in neonates: rethinking dopamine as first-line

Area of Science:

• Neonatal intensive care
• Cardiovascular pharmacology
• Pediatric critical care

Background:

• Dopamine is a primary treatment for hypotension in neonatal intensive care units (NICUs).
• Its role in increasing blood pressure is known, but effects on pulmonary vascular resistance and myocardial function need more investigation.
• Current use may not fully address complex neonatal hemodynamic needs.

Purpose of the Study:

• To review the current use of dopamine in neonatal hemodynamic management.
• To explore alternative vasoactive agents for specific neonatal conditions.
• To advocate for an individualized, physiology-based approach to neonatal cardiovascular support.

Main Methods:

• Literature review of dopamine's hemodynamic effects in neonates.
• Analysis of alternative vasoactive agents and their applications.
• Discussion of evidence-based, individualized treatment strategies.

Main Results:

• Dopamine effectively raises blood pressure but may have variable effects on other hemodynamic parameters.
• Alternative agents offer targeted support for specific pathophysiological states.
• An individualized approach can optimize hemodynamic management.

Conclusions:

• While dopamine is a standard treatment, its use requires careful consideration of potential side effects.
• Tailoring vasoactive therapy to individual neonatal conditions is crucial.
• A shift towards physiology-based cardiovascular support can enhance outcomes in NICU patients.